Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
02/03/1999 | EP0894501A1 Rheumatoid arthritis remedy containing anti-il-8 antibody as active ingredient |
02/03/1999 | EP0894269A1 Tfiib transcription factor from candida albicans |
02/03/1999 | EP0894144A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
02/03/1999 | EP0894141A1 Hybrid proteins which form heterodimers |
02/03/1999 | EP0894140A1 Allele suppression |
02/03/1999 | EP0894139A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
02/03/1999 | EP0894137A1 Novel human myeloid terminal differentiation response gene |
02/03/1999 | EP0894136A1 Method of treating muscular disorders |
02/03/1999 | EP0894135A1 Multivalent and multispecific antigen-binding protein |
02/03/1999 | EP0894134A1 Exodus chemokine materials and methods |
02/03/1999 | EP0894133A2 Neuropeptide y receptor y5 and nucleic acid sequence |
02/03/1999 | EP0894132A2 Adam proteins and uses thereof |
02/03/1999 | EP0894131A1 Human hyaluronan receptor |
02/03/1999 | EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use |
02/03/1999 | EP0894129A1 Short external guide sequences |
02/03/1999 | EP0894094A1 Process for extraction of a growth factor complex |
02/03/1999 | EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof |
02/03/1999 | EP0894092A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp. |
02/03/1999 | EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY |
02/03/1999 | EP0894004A1 Methods for enhancing functional recovery following central nervous system ischemia or trauma |
02/03/1999 | EP0894003A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors |
02/03/1999 | EP0894002A1 Novel peptides which inhibit complement activation |
02/03/1999 | EP0893991A1 Stimulation of immune response with low doses of interleukin-2 |
02/03/1999 | EP0893968A1 Poly(amino acid) adhesive tissue grafts |
02/03/1999 | EP0705275B1 Asp-b28 insulin crystals |
02/03/1999 | EP0510186B1 Therapeutic uses of melanin |
02/03/1999 | CN1207132A Psudomonas exotoxin-myelin basic protein chimeric proteins |
02/03/1999 | CN1207131A Recombinant fusion proteins to growth hormone and serum albumin |
02/03/1999 | CN1207126A Ligand polypeptides for the G-protein-coupled receptor protein, their production and use |
02/03/1999 | CN1207047A Cartilage/bone inducing materials for reparation |
02/03/1999 | CN1207046A Type IX collagen and chimeras |
02/03/1999 | CN1207045A Nisin in combination with glycerol monolaurate active against helicobacter |
02/03/1999 | CN1207044A Cyclosporin-containing soft capsule preparations |
02/03/1999 | CN1207043A Inhibitors of cyclophilin rotamase activity |
02/03/1999 | CN1207042A A Pharmaceutical composition for the treatment of autommune diseases |
02/03/1999 | CN1206715A Amino-acid derivant and preparation process thereof, and medicinal composition containing same |
02/03/1999 | CN1041919C N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists |
02/02/1999 | USRE36080 Therapy sickle cell anemia |
02/02/1999 | US5866699 Oligonucleotides with anti-MDR-1 gene activity |
02/02/1999 | US5866697 The dna is useful for probes to detect the dna in the herpesvirus, for expression to produce the glycoproteins can be used for producing the antibodies which specifically recognize the three glycoprotein antigens. |
02/02/1999 | US5866696 Combination of vector and promoter can be used to introduce and express a human gene and correct a genetic defect in human cells resulting from malfunction of the mutant endogenous gene. |
02/02/1999 | US5866694 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates |
02/02/1999 | US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host. |
02/02/1999 | US5866692 Process for producing humanized chimera antibody |
02/02/1999 | US5866690 Human anti-malignin antibody |
02/02/1999 | US5866689 Monoclonal antibodies to GP130 protein |
02/02/1999 | US5866686 Nuclear thyroid hormone receptor-interacting polypeptides and related molecules and methods |
02/02/1999 | US5866685 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
02/02/1999 | US5866684 Peptidyl inhibitors of viral proteases |
02/02/1999 | US5866682 Short peptides about 14-17 residues in length, which are naturally available in minute amounts in the venom of the cone snails. |
02/02/1999 | US5866681 Oligopeptides |
02/02/1999 | US5866679 Peptides |
02/02/1999 | US5866604 Thiol derivatives with metallopeptidase inhibitory activity |
02/02/1999 | US5866584 Administration of a dopamine agonist, over a limited period at a time of day dependent on the normal circadian rhythm of insulin resistant and insulin sensitive members of a similar species. |
02/02/1999 | US5866570 Treatment of vascular leakage and related syndrome such as septic shock by administration of metalloproteinase inhibitors |
02/02/1999 | US5866551 Therapy for atherosclerosis |
02/02/1999 | US5866550 Method of inhibiting replication of hyperproliferative cells using a nucleic acid encoding EIA |
02/02/1999 | US5866547 Methods of neuroendocrine regulation of affective disorders |
02/02/1999 | US5866546 Administering immunoregulator and cell proliferative agent |
02/02/1999 | US5866545 Antiinflammatory agents; nervous system disorders; gastrointestinal disorders; urogenital disorders |
02/02/1999 | US5866543 Dna expression system |
02/02/1999 | US5866542 Nematode-extracted anticoagulant protein |
02/02/1999 | US5866541 Genetic engineering |
02/02/1999 | US5866540 Cyclic adhesion inhibitors |
02/02/1999 | US5866539 Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
02/02/1999 | US5866538 Stability; mixture with glycerol and(or) mannitol |
02/02/1999 | US5866537 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids |
02/02/1999 | US5866536 Compounds and compositions for delivering active agents |
02/02/1999 | US5866535 Forming antibodies |
02/02/1999 | US5866418 Filtration; ion exchanging; ulcers, gastrointestinal disorders |
02/02/1999 | US5866412 Chromosome 18 marker |
02/02/1999 | US5866403 Homologously recombinant slow growing mycobacteria and uses therefor |
02/02/1999 | US5866402 Chimeric MCP and DAF proteins with cell surface localizing domain |
02/02/1999 | US5866390 Leucyl tRNA synthetase polynucleotides of streptococcus |
02/02/1999 | US5866384 Cell ablation using trans-splicing ribozymes |
02/02/1999 | US5866373 Polynucleotide encoding a human chemotactic protein |
02/02/1999 | US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.? |
02/02/1999 | US5866369 Amps |
02/02/1999 | US5866367 Gidb |
02/02/1999 | US5866366 gidB |
02/02/1999 | US5866365 Utilizing rnc polypeptides to screen for antibacterial compounds. |
02/02/1999 | US5866364 Recombinant bone morphogenetic protein heterodimers |
02/02/1999 | US5866363 Method and means for sorting and identifying biological information |
02/02/1999 | US5866360 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
02/02/1999 | US5866351 CD4+ T-lymphocyte proteases and genes encoding said proteases |
02/02/1999 | US5866332 Diagnosis and treatment of disease states related to proliferation, specifically myeloproliferative diseases and leukemias. |
02/02/1999 | US5866329 Method and probe for detection of gene associated with liver neoplastic disease |
02/02/1999 | US5866327 Association of kinensin with sensitivity to chemotherapeutic drugs |
02/02/1999 | US5866325 Hybrids; detection, quantitative analysis |
02/02/1999 | US5866323 Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors |
02/02/1999 | US5866319 Dna probe capacble of hybridizing with genome |
02/02/1999 | US5866159 Pharmaceutical compositions comprising cyclosporins |
02/02/1999 | US5866136 Recombinant vaccine |
02/02/1999 | US5866134 Administering polysaccharide antibody and interleukins |
02/02/1999 | US5866131 Recombinant vaccine |
02/02/1999 | US5866130 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
02/02/1999 | US5866129 Method of producing an antibody with a peptide corresponding to membrane-bound IgA |
02/02/1999 | US5866127 Vascular permeability factor targeted compounds |
02/02/1999 | US5866126 Complexing |
02/02/1999 | US5866125 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |